Relevant experience working with Elisa on bioanalytical methods in a GLP or GLP like environment.
Work experience in the management of scientific databases. Good knowledge of lab systems: equipment and software.
Very good knowledge of analysis of peptides/proteins/mAbs by High Resolution Mass Spectrometry on Q-TOF
Good work experience with (U)HPLC. Knowledge in methods application and validation.
Relevant work experience in a similar role. Team Player with ability to promote "Lean Thinking".
Bonne connaissance du langage SQL, capacité d'analyse et de créativité.
Very good knowledge of HPLC in a regulated environment in applying analytical methods based on existing protocols. Fluent in French.
Réalisation de tests analytiques en HPLC - (U)HPLC.
Strong technical skills in (U)HPLC. Experience in methods development and validation in a GMP environment.
Work experience with Cell lines and/or proteins using at least one the following techniques: Cytotoxicity testing, Reporter gene assays, Cell death, Proliferation, SDS-PAGE, Western Blot, IEF, ELISA, biacore, octet and protein dosage.
Scientific background with relevant work experience with either Electrophoresis or liquid Chromatography techniques. Fluent in French.
Master’s degree in Industrial Pharmacy and certified Qualified Person by FAMHP.
10 reasons to join us
Work needs fun. We’re fond of sports practice, food trucks, team buildings activities and celebrations.
Integrity and honesty in every interaction with our candidates, staff, clients and partners.
Competitive salary + attractive package including e.g. a company car, meal vouchers, group insurance, hospitalisation, etc.
We care about your health and work-life balance.
A real partner
A sound training program and continuous coaching to grow together and advance your career and skill set.
We offer a pleasant workplace located in the countryside, surrounded by woods, fields and birds.
Passion for excellence in everything we do.
Make an impact on public health by contributing to the analytical development of 500 innovative drugs by end 2020.